Funding and support

The Editoral Base of Cochrane Haematology (CH)  is funded under the auspices of the German Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe e.V.,  European Hematology Association (EHA), Institute for Quality and Efficiency in Healthcare (IQWIG), European Respiratory Society (ERS), World Health Organization (WHO), Deutschen Forschungsgemeinschaft (DFG), in addition by the funding programme Köln Fortune from the medical faculty University of Cologne.

 

The following projects are currently funded by the German Federal Ministry of Education and Research:

  • First-line therapy for adult patients with advanced renal cell carcinoma: a living systematic review (BMBF grant application, No: 01KG1901)
  • Interventions to treat fatigue in adult cancer patients: a Cochrane systematic review with meta-analysis (BMBF grant application, No: 01KG2017)
  • Physical Intervention for patients with Morbus Parkinson: A systematic review with network meta analysis (BMBF grant, No: 01KG1902)
  • Vaccines for cancer patients: a Cochrane systematic review with meta-analyses (BMBF grant, No: KS2020-143)
  • Prognostic factors for predicting treatment success and safety of chimeric antigen receptor (CAR) T-cell therapy in adult aggressive large B-cell lymphomas (PREDICART) (BMBF grant, No: 01KG2204)

 

The following projects are funded by the German Cancer Aid:

  • Update of the interdisciplinary evidence-based guideline for Hodgkin´s Lymphoma in Adults, diagnosis, treatment and follow-up (Funding provided by the German Cancer Aid)
  • Interdisciplinary evidence-based guideline for diagnosis, therapy and follow-up of mature patients with diffuse large B-cell-lymphoma (Funding provided by the German Cancer Aid)

 

The following projects are currently funded by the EHA:

  • Standards in the use and reporting of patient-reported outcomes (EHA-Pro)
  • Evidence-based EHA guideline on cardiovascular toxicity of drugs used in patients with haematological malignancies: guideline for patients with multiple myeloma
  • Evidence-based EHA Guideline: Diagnosis and treatment of chronic neutropenia

 

The following project is currently funded by the DFG:

  • Assessment of the current state of consideration of the specificity of time-to-event analyses in meta-analyses: re-analysis of systematic reviews and implementation of action guidance (SK 146/2-1)